Papers in JHEP Reports
Page 7 · newest first
- A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefitsJHEP Reports · 2025
- Pre-emptive TIPS with 8-mm stents reduces hepatic encephalopathy without compromising efficacy in acute variceal bleedingJHEP Reports · 2025
- Artificial intelligence predicts outcome-related molecular profiles and vascular invasion in hepatocellular carcinomaJHEP Reports · 2025
- Hepatocyte iron suppresses liver fibrosis via fibrolytic neutrophil recruitment in cholestasisJHEP Reports · 2025
- Tumor peripheral stiffness modulates lenvatinib resistance in HCC preclinical models by regulating FIS1-dependent mitophagyJHEP Reports · 2025
- Primary percutaneous stenting for palliative biliary drainage of patients with malignant hilar biliary obstruction: TESLA trialJHEP Reports · 2025
- Diagnostic accuracy of transient elastography in MASLD is independent of MRI-PDFF steatosis in a multicenter studyJHEP Reports · 2025
- Prognostic value of radiological and pathological complete response following immune-based conversion therapy in patients with unresectable hepatocellular carcinoma (GUIDANCE004)JHEP Reports · 2025
- The ‘social gradient' in primary liver cancer in France: A national observational studyJHEP Reports · 2025
- Non-invasive tests for MetALD and alcohol-related liver diseaseJHEP Reports · 2025
- Hepatocellular carcinoma: Epidemiology, diagnosis and treatmentJHEP Reports · 2025
- Evaluating large language models' performance in answering common questions on drug-induced liver injuryJHEP Reports · 2025
- Improved survival in patients with refractory variceal bleeding treated with esophageal stents: A multicenter cohort studyJHEP Reports · 2025
- An engineered human hepatitis A virus capable of rapid proliferation in vitro and causing hepatitis in miceJHEP Reports · 2025
- Disparate patterns of disease time burden in patients with HCC on immunotherapy or tyrosine kinase inhibitorsJHEP Reports · 2025
- Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitisJHEP Reports · 2025
- Time for a globally unified chronic HBV terminology?JHEP Reports · 2025
- Alcohol-related hepatitis induces a specific fibrosis profile through YAP activation in myofibroblastsJHEP Reports · 2025
- Liver transplantation for HCC with macrovascular invasion: A systematic review and meta-analysis of observational studiesJHEP Reports · 2025
- Rectus femoris ultrasound identifies sarcopenia and predicts poor outcomes in patients with acute decompensation of cirrhosisJHEP Reports · 2025
- Non-canonical splice variant of PFKFB4 in hepatocellular carcinoma activates AKT through direct interactionJHEP Reports · 2025
- Platelet protease nexin-1 limits fibrinolysis in patients with cirrhosisJHEP Reports · 2025
- Anatomical resection is associated with reduced early recurrences in HCC: A machine learning analysisJHEP Reports · 2025
- Immunologic effects of locoregional therapies for unresectable hepatocellular carcinomaJHEP Reports · 2025
- Real-world work productivity is impaired in people with metabolic dysfunction-associated steatotic liver disease in the USAJHEP Reports · 2025
- A pathomics-integrated multimodal model to evaluate chemoimmunotherapy efficacy in unresectable intrahepatic cholangiocarcinomaJHEP Reports · 2025
- Nogo-B impairs efferocytosis in monocyte-derived macrophages and exacerbates septic liver injuryJHEP Reports · 2025
- Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosisJHEP Reports · 2025
- Point-of-care ultrasound of the inferior vena cava for intravascular volume assessment during intravenous albumin infusion in patients with cirrhosisJHEP Reports · 2025
- TAF15 in tumor-associated macrophages enhances protumorigenic polarization and promotes cholangiocarcinoma progressionJHEP Reports · 2025
- R-spondin 2 suppresses hepatic steatosis via activation of AMPK-ACC signalingJHEP Reports · 2025
- RAC1 as a novel therapeutic target for acute liver failureJHEP Reports · 2025
- Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide studyJHEP Reports · 2025
- Overt hepatic encephalopathy after elective and preemptive TIPS: Risk factors and prognosisJHEP Reports · 2025
- Adipose microsomal triglyceride transfer protein deficiency protects against hepatic steatosis by upregulating PPARα activityJHEP Reports · 2025
- Mildly elevated liver lipid content is characterised by reduced insulin sensitivityJHEP Reports · 2025
- What we missed then, AI sees now: Revisiting legacy large extracellular vesicle data to reveal synergistic biomarkers for liver cancer screeningJHEP Reports · 2025
- Kinase suppressor of Ras 1 (KSR1) promotes liver carcinogenesis via activation of the RAS/RAF/MEK/ERK signaling pathwayJHEP Reports · 2025
- Targeting fibrosis and steatohepatitis through the metabolism – results from the ESSENCE trialJHEP Reports · 2025
- Relative exchangeable copper: A highly specific and sensitive biomarker for Wilson disease diagnosisJHEP Reports · 2025
- Intratumoral microbial heterogeneity in HCC reveals a potential therapeutic targetJHEP Reports · 2025
- Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLDJHEP Reports · 2025
- NTCP ubiquitination enables HBV infectionJHEP Reports · 2025
- PSMA immunohistochemistry as a diagnostic biomarker of hepatocellular carcinomaJHEP Reports · 2025
- MELD 3.i: A Bayesian framework for updating the model for end-stage liver disease scoreJHEP Reports · 2025
- Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in AsiaJHEP Reports · 2025
- Proteomic signatures reflect effects of semaglutide treatment for MASHJHEP Reports · 2025
- Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinomaJHEP Reports · 2025
- Conjugated bile acid-driven CD14+CD16+ monocyte infiltration promotes cholestatic liver injury by enhancing hepatocyte necroptosisJHEP Reports · 2025
- Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN studyJHEP Reports · 2025